About Nidhi Agarwal
Nidhi is passionate about the capital market and wealth management, which led her to pursue a career as an investment analyst. She holds a bachelor's degree in finance and marketing and is pursuing the CFA program.
Her fundamental approach to analyzing stocks helps investors identify the best investment opportunities.
Recent Articles By Nidhi Agarwal
U.S. vs. China: Which Tech Giant Should Investors Buy?
The technology industry is experiencing a significant expansion due to rising global IT expenditures among enterprises on digital transformation initiatives and the rapid adoption of emerging technologies. Amid this, let’s analyze Microsoft (MSFT) and Tencent Holdings (TCEHY) to determine which tech stock is an ideal buy now. Read on to find out...
3 Home Goods Stocks With Attractive Valuations
With the surge in home remodeling activities, the growing trend of DIY projects, and technological advancements like smart home devices, the home improvement industry is well-positioned for significant expansion. Hence, it could be wise to buy top home goods stocks Home Depot (HD), ADT (ADT), and Kingfisher (KGFHY) with attractive valuations. Read more...
May Growth Potential Analysis for NFLX vs. META
The evolution of user experiences and technological advancements is shaping the future of the Internet industry. With this in mind, let's compare the growth potential of Netflix (NFLX) and Meta Platforms (META) to determine which has the better prospects this month. Read on to discover more...
3 Software Stocks Trading at Attractive Prices
With the surge in demand for custom software solutions across various industries and the rapid adoption of advanced technologies, the software industry is poised for a prosperous future. This makes it a prudent move to consider investing in fundamentally strong software stocks WalkMe (WKME), American Software (AMSWA), and Rimini Street (RMNI), which are currently trading at attractive prices. Read on...
3 Pharma Stocks Primed for May Investment Opportunities
The pharma industry is poised for tremendous growth driven by surging healthcare needs, the introduction of groundbreaking medications, and relentless technological innovation. Hence, quality pharma stocks Collegium Pharmaceutical (COLL), Green Thumb Industries (GTBIF), and Bristol-Myers Squibb (BMY) emerge as prime investment options this month. Read more…
Breaking Down Non-U.S. E-Commerce Giants: PDD vs. JD
Despite the weakening real estate sector and other macro challenges, the Chinese economy has demonstrated remarkable resilience, as highlighted by GDP growth of 5.3% in the first quarter, beating market expectations. Amid this, let’s analyze PDD Holdings (PDD) and JD.com (JD) to determine which is the better non-U.S. stock pick. Read more to find out...
3 Software Stocks on the Verge of Skyrocketing
The software industry is witnessing remarkable growth, propelled by digital transformation initiatives, increased adoption of cloud-based services, advancements in AI and automation, and cybersecurity needs. Hence, it could be wise to invest in quality software stocks UiPath (PATH), Twilio (TWLO), and Amdocs (DOX), which are poised for a potential surge. Read on...
3 A-Rated Biotech Stocks for Long-Term Investors
The future of the biotech industry appears bright, driven by extensive usage across healthcare and agriculture alongside rapid advancements in technology. Thus, top biotech stocks Entrada Therapeutics (TRDA), Exelixis (EXEL), and Gilead Sciences (GILD) could be solid buys for long-term investors. These stocks are rated A (Strong Buy) in our proprietary rating system. Read on…
3 Biotech Stocks to Monitor for May Moves
The biotech industry is well poised to flourish, buoyed by its strong emphasis on technology-driven advancements to address complex medical challenges and government funding. Hence, quality biotech stocks Harmony Biosciences Holdings (HRMY), Illumina (ILMN), and Compugen (CGEN) could be ideal watchlist additions for May. Read more…